€44.40
0.36% day before yesterday
Xetra, Dec 27, 05:35 pm CET
ISIN
DE0005659700
Symbol
EUZ
Index
Sector

Eckert & Ziegler Strahlen- und Medizintechnik Stock price

€44.40
+0.32 0.73% 1M
+1.16 2.67% 6M
+7.10 19.03% YTD
+6.57 17.38% 1Y
-43.12 49.27% 3Y
+2.76 6.64% 5Y
+40.08 926.59% 10Y
Xetra, Closing price Fri, Dec 27 2024
-0.16 0.36%
ISIN
DE0005659700
Symbol
EUZ
Index
Sector

Key metrics

Market capitalization €925.54m
Enterprise Value €881.66m
P/E (TTM) P/E ratio 31.48
EV/FCF (TTM) EV/FCF 20.06
EV/Sales (TTM) EV/Sales 3.17
P/S ratio (TTM) P/S ratio 3.33
P/B ratio (TTM) P/B ratio 3.73
Dividend yield 0.10%
Last dividend (FY23) €0.05
Revenue growth (TTM) Revenue growth 14.70%
Revenue (TTM) Revenue €277.70m
EBIT (operating result TTM) EBIT €66.04m
Free Cash Flow (TTM) Free Cash Flow €43.95m
Cash position €97.63m
EPS (TTM) EPS €1.41
P/E forward 24.13
P/S forward 3.19
EV/Sales forward 3.04
Show more

Is Eckert & Ziegler Strahlen- und Medizintechnik a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Eckert & Ziegler Strahlen- und Medizintechnik Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Eckert & Ziegler Strahlen- und Medizintechnik:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Eckert & Ziegler Strahlen- und Medizintechnik:

Buy
100%

Financial data from Eckert & Ziegler Strahlen- und Medizintechnik

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
278 278
15% 15%
100%
- Direct Costs 144 144
11% 11%
52%
133 133
19% 19%
48%
- Selling and Administrative Expenses 53 53
7% 7%
19%
- Research and Development Expense - -
-
-
80 80
29% 29%
29%
- Depreciation and Amortization 14 14
16% 16%
5%
EBIT (Operating Income) EBIT 66 66
32% 32%
24%
Net Profit 29 29
12% 12%
11%

In millions EUR.

Don't miss a Thing! We will send you all news about Eckert & Ziegler Strahlen- und Medizintechnik directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Eckert & Ziegler Strahlen- und Medizintechnik Stock News

EQS
16 days ago
Berlin, 13. Dezember 2024. Die Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler), ein führender Anbieter von Isotopentechnologie für die Nuklearmedizin und radiopharmazeutische Anwendungen, gibt die Einreichung ihres GalliaPharm® 68Ge/68Ga Radionuklid-Generators zur Zulassung in Japan bekannt....
AD HOC NEWS
16 days ago
Eckert & Ziegler SE / DE0005659700
More Eckert & Ziegler Strahlen- und Medizintechnik News

Company Profile

Eckert & Ziegler Strahlen- und Medizintechnik AG engages in the provision of isotope technology for medical, scientific, and industrial use. It operates through the following segments: Radiation Therapy, Isotope Products, and Radiopharma. The Radiation Therapy segment includes the production and distribution of medical products for the treatment of cancer using brachytherapy. The Isotope Products segment manufactures and distributes sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment is specialized in the field of molecular imaging and nuclear medicine, supplying different radiopharmaceuticals, radiochemicals and related equipment for the synthesis and radiochromatography of PET/SPECT tracers and other radioisotopes. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany.

Head office Germany
CEO Harald Hasselmann
Employees 1,075
Founded 1997
Website www.ezag.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today